Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (19) , 3133-3137
- https://doi.org/10.1016/0006-2952(82)90096-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvageBiochemical Pharmacology, 1981
- Analysis by high-pressure liquid chromatography of 9-β-d-arabinofuranosyladenine 5′-triphosphate levels in murine leukemia cellsJournal of Chromatography A, 1977
- AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation, 1968
- Effect of substrate decomposition on the spectrophotometric assay of dihydrofolate reductaseAnalytical Biochemistry, 1967
- Dihydrofolate Reductase from a Resistant Subline of the L1210 LymphomaJournal of Biological Chemistry, 1967
- Uptake as a Determinant of Methotrexate Response in Mouse LeukemiasScience, 1965
- Purification and Properties of Dihydrofolate Reductase from Ehrlich Ascites Carcinoma Cells*Biochemistry, 1965
- A biochemical basis for resistance of L1210 mouse leukemia to 6-thioguanineBiochemical Pharmacology, 1963
- Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cellsBiochemical Pharmacology, 1962
- RESPONSE OF ACUTE LYMPHOCYTIC LEUKEMIAS TO THE PURINE ANTAGONIST 6‐MERCAPTOPURINEAnnals of the New York Academy of Sciences, 1954